Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.
Neuro-Ophthalmology Annual Review.
Facilitating Early-In-Day Discharge for Multiple Sclerosis Patients Treated With Intravenous Methylprednisolone: A Quality Improvement Project.
Brain radiation and possible presentation of multiple sclerosis.
Multiple sclerosis and cancer: When two wrongs make a right?
Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis.
Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach.
[Clinico-radiological profile of acute disseminated encephalomyelitis in the childhood population. A retrospective analysis of a series of 20 patients in a tertiary hospital].
Depression during multiple sclerosis relapse: relation to disability and relapse severity.
Modeling the course and outcomes of MS is statistical twaddle-No.
The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Alterations in nerve-evoked bladder contractions in a coronavirus-induced mouse model of multiple sclerosis.
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada.
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
[New therapeutic options in multiple sclerosis].
Brain iron deposition in white matter hyperintensities: a 3-T MRI study.
Difficulties in Planning Among Patients with Multiple Sclerosis: A Relative Consequence of Deficits in Information Processing Speed.
Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.
Multiple sclerosis increases the risk of infections resulting in a hospitalization among veterans.
The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results.
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
Lipocalin-2 deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
Pages
« first
‹ previous
…
605
606
607
608
609
610
611
612
613
…
next ›
last »